Intelligence Β· Drug directory

EMA-Approved Drugs Directory

European Medicines Agency approved medicines with EPAR-derived status, INN profiles, and competitive intelligence links.

Quick answer

EMA-approved drugs: NovaPharmaNews tracks 931 pharmaceutical drugs in this segment. European Medicines Agency approved medicines with EPAR-derived status, INN profiles, and competitive intelligence links.

931 drugs Β· EMA approved Β· by data quality Β· Page 14 of 39

  1. concizumab

    ALHEMO

    INJECTION FDA: approved Β· EMA: approved Β· PMDA: approved

    B02BX10
  2. crizotinib

    XALKORI Pfizer Australia Pty Ltd

    ORAL FDA: approved Β· EMA: approved Β· TGA: approved Β· PMDA: approved Β· NMPA: clinical trials

    L01ED01
  3. dacomitinib

    VIZIMPRO

    ORAL FDA: approved Β· EMA: approved Β· NMPA: clinical trials

    L01EB07
  4. danicopan

    VOYDEYA

    ORAL FDA: approved Β· EMA: approved Β· PMDA: approved

    L04AJ09
  5. daratumumab

    DARZALEX Janssen-Cilag Pty Ltd

    INJECTION FDA: approved Β· EMA: approved Β· TGA: approved Β· PMDA: approved Β· NMPA: clinical trials

    L01FC01
  6. darbepoetin alfa

    ARANESP Amgen

    SUBCUTANEOUS FDA: approved Β· EMA: approved Β· TGA: approved

    B03XA02
  7. darifenacin hydrobromide

    EMSELEX

    ORAL FDA: approved Β· EMA: approved

    G04BD10
  8. darolutamide

    NUBEQA Bayer Australia Ltd

    ORAL FDA: approved Β· EMA: approved Β· TGA: approved Β· PMDA: approved

    L02BB
  9. decitabine

    DACOGEN

    INTRAVENOUS FDA: approved Β· EMA: approved Β· NMPA: clinical trials

    L01BC08
  10. deferiprone

    FERRIPROX Chiesi Australia Pty Ltd

    ORAL FDA: approved Β· EMA: approved Β· TGA: approved

    V03AC02
  11. delgocitinib

    ANZUPGO

    TOPICAL FDA: approved Β· EMA: approved Β· PMDA: approved

    D11AH11
  12. deucravacitinib

    SOTYKTU Bristol-Myers Squibb Australia Pty Ltd

    ORAL FDA: approved Β· EMA: approved Β· TGA: approved

    L04AF07
  13. diroximel fumarate

    VUMERITY Biogen

    ORAL FDA: approved Β· EMA: approved Β· TGA: approved

    L04AX07
  14. doravirine

    DELSTRIGO

    ORAL FDA: approved Β· EMA: approved

    J05AG06
  15. doxecitine

    KYGEVVI

    ORAL FDA: approved Β· EMA: approved

    A16AX29
  16. dulaglutide

    TRULICITY

    INJECTION FDA: approved Β· EMA: approved Β· TGA: approved Β· NMPA: clinical trials

    A10BJ05
  17. durvalumab

    IMFINZI AstraZeneca

    INJECTION FDA: approved Β· EMA: approved Β· TGA: approved Β· PMDA: approved

    L01XC28
  18. eculizumab

    SOLIRIS Lacuna Pharma Pty Ltd

    IV (INFUSION) FDA: approved Β· EMA: approved Β· TGA: approved Β· PMDA: approved

    L04AA25
  19. edoxaban

    LIXIANA

    ORAL FDA: approved Β· EMA: approved Β· PMDA: approved

    B01AF03
  20. efgartigimod alfa

    VYVGART

    INJECTION FDA: approved Β· EMA: approved Β· PMDA: approved

    L04AA58
  21. elafibranor

    IQIRVO Ipsen

    ORAL FDA: approved Β· EMA: approved Β· TGA: approved

    A05AX06
  22. elbasvir

    ZEPATIER

    ORAL FDA: approved Β· EMA: approved Β· PMDA: approved

    J05AP54
  23. elinzanetant

    LYNKUET

    ORAL FDA: approved Β· EMA: approved

  24. elotuzumab

    EMPLICITI Bristol-Myers Squibb Australia Pty Ltd

    INJECTION FDA: approved Β· EMA: approved Β· TGA: approved Β· PMDA: approved

    L01FX08

Frequently asked questions

How many ema approved drugs are listed?

931 drug profiles match this regulatory segment in our published index.

Where does approval data come from?

Profiles combine FDA Drugs@FDA, EMA EPAR references, and regional authority feeds. See our data sources page for attribution.